10 Followers on Owler

Novira Therapeutics

Novira Therapeutics engages in the research and development of antiviral therapeutics for the treatment of chronic HBV and HIV infections. Read more

Christian S. Schade's photo - CEO of Novira Therapeutics

CEO

Christian S. Schade

CEO Approval Rating

69/100

Founded:

2009

Status:

Out Of Business

Est. Annual Revenue
Est. Employees
Sector

Update Industry

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Apple a competitor of Novira Therapeutics?

Novira Therapeutics Acquisitions

No recent acquisitions found related to Novira Therapeutics

Novira Therapeutics Funding History

Since Novira Therapeutics was founded in 2009, it has participated in 4 rounds of funding. In total Novira Therapeutics has raised $42.0M. Novira Therapeutics' last funding round was on Dec 2014 for a total of $9.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Dec 2014
$9M
Series A
Mar 2013
$7.5M
Series A
Aug 2012
$23M
Seed
Jul 2011
$2.5M

Robin Hood Ventures

Since Novira Therapeutics was founded in 2009, it has participated in 4 rounds of funding. In total Novira Therapeutics has raised $42.0M. Novira Therapeutics' last funding round was on Dec 2014 for a total of $9.0M

Novira Therapeutics Investments

No recent investments found related to Novira Therapeutics

Novira Therapeutics News

November 9, 2015FINSMEs

Johnson & Johnson Acquires Novira Therapeutics

Novira Therapeutics Inc., a Doylestown, MA-based...... See more »
November 6, 2015BIOPORTFOLIO

J&J to acquire Novira Therapeutics

David SalazarNovira is a company working on curative treatments for chronic hepatitis B. read more... See more »
November 6, 2015BIOSPACE

WuXi PharmaTech Congratulates Novira Therapeutics

SHANGHAI, Nov. 5, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: studio-5.financialcontent... See more »
November 5, 2015PE HUB

J & J to acquire VC-backed Novira Therapeutics

Johnson & Johnson has agreed to buy Novira Therapeutics Inc, a biopharmaceutical company focused on d... See more »
November 5, 2015MANUFACTURING CHEMIST

Johnson and Johnson to purchase Novira Therapeutics

Will complement and strengthen J&J's existing pipeline to combat Hepatitis B... See more »
November 5, 2015BIOCENTURY

J&J acquiring Novira

Johnson & Johnson (NYSE:JNJ) will acquire HBV play Novira Therapeutics Inc. (Doylestown, Pa.) for an ... See more »
November 4, 2015PHILADELPHIA BUSINESS JOURNAL

J&J to buy Bucks County biopharm firm focused on curing hepatitis B

Johnson & Johnson entered into a definitive agreement Wednesday to acquire Novira Therapeutics Inc., ... See more »

Novira Therapeutics Press Releases

Social Media

Novira Therapeutics Headquarters

3805 Old Easton Rd

Doylestown, Pennsylvania18902

267-337-6913

Driving Directions »

Trending Companies

Novira Therapeutics Summary

ABOUT

Overview

Novira Therapeutics engages in the research and development of antiviral therapeutics for the treatment of chronic HBV and HIV infections. Novira Therapeutics was founded in 2009. Novira Therapeutics' headquarters is located in Doylestown, Pennsylvani...

CEO

Novira Therapeutics's CEO, Christian S. Schade, currently has an approval rating of 69%. Novira Therapeutics's primary competitors are

Frequently Asked Questions about Novira Therapeutics

  1. When was Novira Therapeutics founded?

    Novira Therapeutics was founded in 2009
  2. Who is Novira Therapeutics's CEO?

    Novira Therapeutics's CEO is Christian S. Schade
  3. How much revenue does Novira Therapeutics generate?

    Novira Therapeutics generates $ < 1M in revenue
  1. How much funding does Novira Therapeutics have?

    Novira Therapeutics has historically raised $42M in funding
  2. Where is Novira Therapeutics's headquarters?

    Novira Therapeutics's headquarters is in Doylestown Pennsylvania, USA
  3. How many employees does Novira Therapeutics have?

    Novira Therapeutics has 89 employees